Lipids, lipoproteins, antioxidants and glomerular and tubular dysfunction in type 1 diabetes
Sheila F. O’Brien(University of Ottawa), Nicholas J. Miller(Guy's Hospital), Jake Powrie(Guy's and St Thomas' NHS Foundation Trust), Kenneth Shaw(St Thomas' Hospital), Gerald F. Watts(Royal Perth Hospital)
Cited by 12
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k